The opinion magazine of the American Gastroenterological Association
Barrett’s esophagus is a metaplastic change of the esophageal epithelium which increases the risk of esophageal adenocarcinoma by 10 to 30 fold. It is thought to progress via the development of dysplasia to esophageal adenocarcinoma (EAC). EAC is a lethal malignancy with poor outcomes when diagnosed after the onset of symptoms despite recommendations for screening […]
Aspirin is a commonly prescribed drug and its prevention of both cardiovascular and vascular events is well established. Recently, the benefits of aspirin from a chemoprevention standpoint, particularly in gastrointestinal tract cancers, have emerged. Prevention of esophageal adenocarcinomas is particularly relevant for Barrett’s esophagus patients, a premalignant condition affecting 2 percent of the adult population. […]
Barrett’s esophagus is a metaplastic change of the esophageal epithelium which increases the risk of esophageal adenocarcinoma by 10 to 30 fold. It is thought to progress via the development of dysplasia to esophageal adenocarcinoma (EAC). EAC is a lethal malignancy with poor outcomes when diagnosed after the onset of symptoms despite recommendations for screening […]
Aspirin is a commonly prescribed drug and its prevention of both cardiovascular and vascular events is well established. Recently, the benefits of aspirin from a chemoprevention standpoint, particularly in gastrointestinal tract cancers, have emerged. Prevention of esophageal adenocarcinomas is particularly relevant for Barrett’s esophagus patients, a premalignant condition affecting 2 percent of the adult population. […]
The Rome Foundation Working Team Report1 brings together a wealth of data and reminds us just how productive this area of research has been for the understanding of the mechanisms underlying functional bowel disorders. Clinicians are presented daily with patients meeting the Rome criteria for irritable bowel and will be well aware of how heterogeneous […]
In November of 2002, 11 esophageal physiologists gathered in Porto to consolidate knowledge surrounding a new technology: intraluminal impedance monitoring. After decades of dependence on pH testing to define reflux, experts were wrestling with a growing body of evidence showing that not all reflux episodes, or symptoms, were associated with low pH.1,2 The resulting consensus […]
We aim to provide the highest quality of care for our patients. But what is health care “quality”? It is a multi-faceted concept, but one widely accepted definition is to “improve desired health outcomes” by providing care that is “safe, effective, timely, efficient, equitable and people-centered” (WHO 2019). AGA aspires to make high-quality care a […]
In recent years there have been exciting advances in gastroenterology due to the novel application of artificial intelligence (AI) and other machine learning (ML) based technologies towards solving certain problems that were herein considered to be under exclusive domains of physicians. The various applications of AI and ML in GI are towards detection, diagnosis and […]
Over the past five years, practicing endoscopists have become acutely aware of the risk to patients from duodenoscope contamination related to the fact that these instruments can continue to harbor bacteria despite adherence to reprocessing protocols recommended by endoscope manufacturers. This conundrum is ultimately distilled for patients as an unquantifiable risk of intestinal colonization and/or […]
Why inflammatory bowel disease? Inflammatory bowel disease (IBD) is a costly and chronic medical condition that disproportionately affects a young population demographic. IBD patients have unique behavioral, preventative and therapeutic health care needs.1 Due to care complexity, management is often fragmented amongst multiple providers, frequently across health care systems with the burden of coordination, communication […]
Stay Connected